- Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Annals of the rheumatic diseases. 2013 Academic Article GET IT
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice.
Annals of the rheumatic diseases.
Times cited: 47
- Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire. Annals of the rheumatic diseases. 2011 Academic Article GET IT